| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 antagonist/killer 1 | 0.555 | 0.769 | 7.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BCL2 like 11 | 0.510 | 0.731 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
bromodomain containing 3 | 0.700 | 0.500 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
bromodomain PHD finger transcription factor | 0.560 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
BUD13 homolog | 0.751 | 0.538 | 2.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
C-C motif chemokine ligand 24 | 0.608 | 0.731 | 7.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
C-C motif chemokine receptor 3 | 0.527 | 0.808 | 1.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
C-X-C motif chemokine receptor 2 | 0.445 | 0.923 | 1.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2016 | 2016 | |||||||||
|
cAMP responsive element binding protein 5 | 0.682 | 0.538 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
carbonic anhydrase 11 | 0.674 | 0.385 | 9.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
carbonic anhydrase 5A | 0.686 | 0.500 | 7.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CCAAT enhancer binding protein epsilon | 0.674 | 0.385 | 7.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2018 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2016 | 2018 | |||||||||
|
CD164 molecule | 0.674 | 0.462 | 0.49 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
CD200 molecule | 0.529 | 0.769 | 0.41 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CD200 receptor 1 | 0.623 | 0.769 | 4.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CD300 molecule like family member f | 0.716 | 0.385 | 1.1E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cereblon | 0.551 | 0.654 | 2.9E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | ||||||||
|
chondroitin sulfate synthase 1 | 0.612 | 0.615 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 |